Jeremie Calais, MD, from the University of California, Los Angeles, CA, talks about 18F-fluciclovine (AXUMIN) vs 68Ga-PSMA-11 (PSMA) PET/CT molecular imaging in prostate cancer. This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.
